Preliminary Results 2023
A Global Leader in Pest Control and Hygiene & Wellbeing Services
Relentless Execution of our Plan
7 March 2024
Cautionary statement
In order to utilise the 'safe harbour' provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the "PSLRA") and the general doctrine of cautionary statements, Rentokil Initial plc ("the Company") is providing the following cautionary statement: This communication contains forward-looking statements within the meaning of the PSLRA. Forward-looking statements can sometimes, but not always, be identified by the use of forward-looking terms such as "believes," "expects," "may," "will," "shall," "should," "would," "could," "potential," "seeks," "aims," "projects," "predicts," "is optimistic," "intends," "plans," "estimates," "targets," "anticipates," "continues" or other comparable terms or negatives of these terms and include statements regarding Rentokil Initial's intentions, beliefs or current expectations concerning, amongst other things, the results of operations of the Company and its consolidated entities ("Rentokil Initial" or "the Group") (including preliminary results for the year ended 31 December 2023), financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which Rentokil Initial operates. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialise, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The Company can give no assurance that such plans, estimates or expectations will be achieved and therefore, actual results may differ materially from any plans, estimates or expectations in such forward-looking statements. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include: the Group's ability to integrate acquisitions successfully, or any unexpected costs or liabilities from the Group's disposals; difficulties in integrating, streamlining and optimising the Group's IT systems, processes and technologies; the availability of a suitably skilled and qualified labour force to maintain the Group's business; the Group's ability to attract, retain and develop key personnel to lead the business; the impact of environmental, social and governance ("ESG") matters, including those related to climate change and sustainability, on the Group's business, reputation, results of operations, financial condition and/or prospects; inflationary pressures, such as increases in wages, fuel prices and other operating costs; supply chain issues, which may result in product shortages or other disruptions to the Group's business; weakening general economic conditions, including changes in the global job market, or decreased consumer confidence or spending levels especially as they may affect demand from the Group's customers; the Group's ability to implement its business strategies successfully, including achieving its growth objectives; the Group's ability to retain existing customers and attract new customers; the highly competitive nature of the Group's industries; cyber security breaches, attacks and other similar incidents, as well as disruptions or failures in the Group's IT systems or data security procedures and those of its third-party service providers; extraordinary events that impact the Group's ability to service customers without interruption, including a loss of its third-party distributors; the Group's ability to protect its intellectual property and other proprietary rights that are material to the Group's business; the Group's reliance on third parties, including third-party vendors for business process outsourcing initiatives, investment counterparties, and franchisees, and the risk of any termination or disruption of such relationships or counterparty default or litigation; the identification of material weaknesses in the Group's internal control over financial reporting within the meaning of Section 404 of the Sarbanes-Oxley Act; any future impairment charges, asset revaluations or downgrades; failure to comply with the many laws and governmental regulations to which the Group is subject or the implementation of any new or revised laws or regulations that alter the environment in which the Group does business, as well as the costs to the Group of complying with any such changes; termite damage claims and lawsuits related thereto and any associated impacts on the termite provision; the Group's ability to comply with safety, health and environmental policies, laws and regulations, including laws pertaining to the use of pesticides; any actual or perceived failure to comply with stringent, complex and evolving laws, rules, regulations and standards in many jurisdictions, as well as contractual obligations, including data privacy and security; changes in tax laws and any unanticipated tax liabilities; adverse credit and financial market events and conditions, which could, among other things, impede access to or increase the cost of financing; the restrictions and limitations within the agreements and instruments governing our indebtedness; a lowering or withdrawal of the ratings, outlook or watch assigned to the Group's debt securities by rating agencies; an increase in interest rates and the resulting increase in the cost of servicing the Group's debt; and exchange rate fluctuations and the impact on the Group's results or the foreign currency value of the Company's ADSs and any dividends. The list of factors presented here is representative and should not be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realisation of forward-looking statements. The Company cautions you not to place undue reliance on any of these forward-looking statements as they are not guarantees of future performance or outcomes and that actual performance and outcomes, including, without limitation, the Group's actual results of operations, financial condition and liquidity, and the development of new markets or market segments in which the Group operates, may differ materially from those made in or suggested by the forward-looking statements contained in this communication. Except as required by law, Rentokil Initial assumes no obligation to update or revise the information contained herein, which speaks only as of the date hereof.
Additional information concerning these and other factors can be found in Rentokil Initial's filings with the U.S. Securities and Exchange Commission ("SEC"), which may be obtained free of charge at the SEC's website, http:// www.sec.gov, and Rentokil Initial's Annual Reports, which may be obtained free of charge from the Rentokil Initial website, https://www.rentokil-initial.com
No statement in this communication is intended to be a profit forecast and no statement in this communication should be interpreted to mean that earnings per share of Rentokil Initial for the current or future financial years would necessarily match or exceed the historical published earnings per share of Rentokil Initial.
This communication presents certain further non-IFRS measures, which should not be viewed in isolation as alternatives to the equivalent IFRS measure, rather they should be viewed as complements to, and read in conjunction with, the equivalent IFRS measure. These include revenue and profit measures presented at actual exchange rates ("AER" - IFRS) and constant full year 2022 exchange rates ("CER" - Non-GAAP).Non-IFRS measures include Adjusted Operating Profit, Adjusted Profit Before Tax, Adjusted Profit After Tax, Adjusted EBITDA, Adjusted Interest, Adjusted Earnings Per Share , Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion, Adjusted Effective Tax rate and Organic Revenue, Adjusted Operating Profit represents the performance of the continuing operations of the Group (including acquisitions), and enables the users of the accounts to focus on the performance of the businesses retained by the Group, and that will therefore contribute to the future performance. Adjusted Operating Profit and Adjusted profit before tax exclude certain items that could distort the underlying trading performance. The Group's internal strategic planning process is also based on these measures, and they are used for incentive purposes. These measures may not be calculated in the same way as similarly named measures reported by other companies
2
Agenda | Preliminary Results 2023
Introduction and Highlights | Andy Ransom |
Group and Regional Financial Results | Stuart Ingall-Tombs |
Operating Model and our Business Categories | Andy Ransom |
North America: Analysis of Organic Growth in H2 2023 | Andy Ransom |
North America: THE RIGHT WAY 2 Plan for Organic Growth | Brad Paulsen |
North America: Integration Update | Andy Ransom |
Q&A | All |
3
2023 | Group Highlights
£5.4bn | +4.9% | £897m | ||||||||
FULL YEAR REVENUE | ORGANIC REVENUE GROWTH | ADJUSTED OPERATING PROFIT | ||||||||
GROWTH OF 45.8% | GROWTH OF 57.0% | |||||||||
£1.2bn c.£106m 89.4%
ADJUSTED EBITDA (AER) | ACQUIRED BOLT-ON REVENUE | ADJUSTED FREE |
CASH FLOW CONVERSION | ||
GROWTH OF 43.0% | (41 DEALS) | |
FREE CASH FLOW £500m (AER) | ||
At CER unless otherwise stated
Organic Growth excl. Disinfection
16.6%
ADJUSTED OPERATING MARGIN
GROWTH OF 120bps
North America margin at 18.7%
2.8x
NET DEBT TO EBITDA RATIO
Below target of < 3.0x,
one year early
Good Overall Group Performance
4
2023 | Medium-term Targets
Our plan to create a higher quality business
Medium-term Revenue growth of 6% - 9%
Medium-term Organic Revenue >5%
Pest Control: 4.5% - 6.5%. H&W: 4% - 6%. Workwear: 3% - 4%
Medium-term Profit growth of 10%+
Adjusted operating margin of 19%+ in 2025 ➔ 2026
FCF conversion of 80% - 90% in FY 23 and FY 24. c.90% in FY 25
Net debt/EBITDA of less than 3x by end FY 24
Deliver value creating bolt-on M&A
and build presence in Cities of the Future
Progressive dividend policy
45.8% Revenue growth in 2023
60.6% Pest Control; 7.8% Core H&W; 13.2% FWW
4.9% Organic growth in 2023 (excl Disinfection)
Pest Control: 4.5%. H&W: 4.8%. Workwear: 13.2%
57.0% Profit growth in 2023. Margins up 120bps to 16.6%
89.4% FCF conversion delivered in 2023 Very encouraging cash performance
Net debt to EBITDA Ratio at year end of 2.8x at end of 2023
BBB (stable outlook) rating from S&P and Fitch
41 deals delivered with annualised revenues of c.£106m in 2023
Substantial pipeline in place
Full year dividend growth of 15.0% delivered in 2023
Policy maintained
Group performing well overall, but North America H2 Organic Growth below plan
Plan in place to reinvigorate growth
H&W: Hygiene & Wellbeing; FWW: France Workwear. At CER unless otherwise stated 5
2023 | North America Pest Control
Increased cost synergy target and THE RIGHT WAY 2 Growth Plan
North America Growth
-
Organic Revenue Growth in NA Pest Control Services:
Below our expectations at 3.5% in 2023 (H1: 5.0%, H2 2.0%) - reduction in organic sales leads - THE RIGHT WAY 2 Growth Plan:
Focus on inbound sales leads from new and existing customers. Highly experienced team in place - Investing for Organic Growth:
Additional c.$25m in 2024 in North American team, leads, digital channels, increasing visibility of the Terminix brand, marketing and sales - Organic Growth in North America: 2 - 4% in 2024
Terminix Integration
- Phase 1 of integration (foundations for success) completed: Delivered net cost synergies of $69m vs target of $60m in 2023
- Deliver Phase 2: (preparation for full integration) and begin Phase 3 with full branch integrations (from mid-year) in 2024
- Co-locations: 97 fewer properties to date, c.75 properties to be exited in 2024
- Deliver $40m net cost synergies in 2024
- Cost synergy target raised: Gross synergies increased by $50m to c.$325m and net synergies by $25m to c.$225m (with c.$25m investment in marketing, etc.), targeted to be delivered by the end of 2026 - derisk branch integration and achieve increased synergy target
6
Preliminary Results 2023
Financial & Regional
Review
Stuart Ingall-Tombs
7
Group Financial Highlights
Revenue | +4.9% Organic Revenue (Excl. Disinfection), | ||||
£5,414m | plus | 41 | bolt-on acquisitions | ||
Profit | +57.0%. Continued price progression | ||||
£897m | offsetting inflation. Margin up 120bps | ||||
Free Cash Flow | |||||
Representing | 89.4% | Adjusted FCF | |||
£500m | conversion (AER) | ||||
Leverage | Net Debt/EBITDA at 2.8x hitting target | ||||
of <3x one year early | |||||
EPS | Diluted Adj. EPS up 8.8% at AER and | ||||
12.9% at CER | |||||
DPS | Based on strength of performance in | ||||
FY +15.0% | 2023 and outlook. FY DPS 8.68p | ||||
FY 2023 | ||||||||||||||||||
Δ | Δ | |||||||||||||||||
£ million | AER | CER | AER | CER | ||||||||||||||
Revenue | 5,375 | 5,414 | 44.7% | 45.8% | ||||||||||||||
Adjusted Operating Profit | 898 | 897 | 57.1% | 57.0% | ||||||||||||||
Adjusted Operating Margin | 16.6% | 120bps | ||||||||||||||||
Adjusted profit before tax | ||||||||||||||||||
766 | 801 | 43.8% | 50.5% | |||||||||||||||
Adjusted EBITDA | 1,228 | 43.0% | ||||||||||||||||
Free Cash Flow | 500 | 33.7% | ||||||||||||||||
Diluted Adjusted EPS | 23.08p | 8.8% | ||||||||||||||||
Dividend per share | 8.68p | 15.0% | ||||||||||||||||
8
North America
2023 | Δ | |
Revenue | £3,314m | +79.2% |
Organic Revenue* | +3.1% | |
Adjusted Operating Profit | £618m | +95.9% |
Adjusted Operating Margin | 18.7% | +160 bps |
61% of Group Revenue | 60% of Adjusted Operating Profit |
2023 Performance:
Organic Revenue +3.1%*
- Pest Control +3.1%; Pest Control services for commercial, residential and termite customers +3.5%
- H2 impacted by lower new business lead generation
Adjusted Operating Profit +95.9%, reflecting higher revenues and the Terminix acquisition
Adjusted Operating Margin +160bps to 18.7% owing to strong synergy delivery (+140bps) and effective mitigation of cost inflation
+5.0ppts in total North America colleague retention to 75.2% Terminix colleague retention up to 69.7% (FY 22: 64.0%)
Resilient customer retention at 79.5% (FY 22: 79.3%)
13 businesses acquired with combined annualised revenues of c.£46m
*Excluding Covid related disinfection. Including disinfection: +3.0% organic
Adjusted Operating Margin +160bps to 18.7%
9
North America Margin - Synergistic and Trading Progress
2023 Performance
North America margin moves forward based on trading and synergies
14.7%
18.0%
1.4%
1.0%
16.3%
18.7%
- Trading incl. growth and density increase margin by c.100bps
- $56m/£45m of synergies in year increase margin by c.140bps
- Margin headwind from lower organic growth and distribution
- Organic growth 190bps off 5% target, an opportunity loss of 40bps
- Lower distribution margin reduced regional margin by c.30bps
- Modest margin progression expected in 2024 with improvement weighted towards H2
Margin Analysis
TMX | RNA | Proforma Trading | Synergies | NA |
NA | 2023 | 2023 | ||
2022 | £45m |
10
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Rentokil Initial plc published this content on 07 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 March 2024 11:35:02 UTC.